A. Colman

Anxiety and depression in Australian chronic hepatitis C outpatients: prevalence and predictors

J. Andrews, A. Mikocka-Walus, M. Phelps, 2012, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.

Real‐world outcomes of unrestricted direct‐acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience

D. Liew, D. Shaw, J. Haridy, 2018, Journal of viral hepatitis.

Outcomes of community‐based hepatitis C treatment by general practitioners and nurses in Australia through remote specialist consultation

D. Liew, G. Hebbard, J. Sasadeusz, 2020, Internal medicine journal.

High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C

Pete J. Frost, D. Shaw, H. Harley, 2010, Journal of gastroenterology and hepatology.

Cost effectiveness of treatment models of care for hepatitis C: the South Australian state-wide experience

B. Kaambwa, R. Woodman, D. Shaw, 2019, European journal of gastroenterology & hepatology.

Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-Pacific hepatitis C virus genotype 1 non-responders/relapsers.

S. Tan, S. Lim, W. Sukeepaisarnjaroen, 2015, World journal of gastroenterology.

Consensus recommendations on the management of hepatitis C in Australia's prisons

A. Lloyd, M. Stoové, G. Macdonald, 2023, Medical Journal of Australia.